Literature DB >> 12100901

Gastrointestinal complications after pediatric cardiac transplantation.

Amit Rakhit1, Samuel Nurko, Kimberlee Gauvreau, John E Mayer, Elizabeth D Blume.   

Abstract

BACKGROUND: The incidence of major gastrointestinal complications after pediatric heart transplantation has not been well characterized. Studies in adults suggest significant morbidity and mortality from post-transplant gastrointestinal complications. In this study, we investigated major gastrointestinal complications in the pediatric heart transplant population.
METHODS: We performed a retrospective analysis of all patients who underwent heart transplantation at Children's Hospital, Boston, including all pertinent clinical, radiologic, endoscopic, and pathologic findings. Between May 1986 and December 2000, 104 patients underwent 105 orthotopic heart transplantations. Gastrointestinal complications were defined as major if they significantly prolonged hospital course, required hospital admission, or required surgical intervention.
RESULTS: Median age at transplant was 8.7 years (range, 2 weeks to 23 years). Median duration of follow-up was 3.3 years (range, 2 days to 14.9 years). All patients initially received standard triple immunosuppression with cyclosporine, prednisone, and azathioprine. During this period, 30 major complication episodes occurred in 19 patients (18%) and included pancreatitis (7), cholecystitis (6), recurrent abdominal infection (5), malignancy (4), intestinal pneumatosis (4), colonic perforation (2), appendicitis (1), Crohn's disease (1), and partial small bowel obstruction (1). Ten (53%) of the 19 patients with major gastrointestinal complications required surgical intervention.
CONCLUSIONS: Serious gastrointestinal complications can occur after pediatric cardiac transplantation, with an incidence similar to that seen in adults. Gastrointestinal symptoms should be aggressively evaluated in the pediatric heart transplant patient because of the high incidence of complications that may require surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12100901     DOI: 10.1016/s1053-2498(02)00383-2

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  [Perioperative implications of heart transplant].

Authors:  H K Eltzschig; B Zwissler; T W Felbinger
Journal:  Anaesthesist       Date:  2003-08       Impact factor: 1.041

2.  Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient.

Authors:  K Puri; S Kocoshis; K Risma; L Perez; C Hart; C Chin; T D Ryan; J L Jefferies; K R Schumacher; C Castleberry
Journal:  Pediatr Transplant       Date:  2015-09-16

3.  Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines.

Authors:  Hideki Yasuda; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Koichi Hirata; Yasutoshi Kimura; Keita Wada; Fumihiko Miura; Masahiko Hirota; Toshihiko Mayumi; Masahiro Yoshida; Masato Nagino; Yuichi Yamashita; Serafin C Hilvano; Sun-Whe Kim
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

Review 4.  The impact of Clostridium difficile on paediatric surgical practice: a systematic review.

Authors:  D Mc Laughlin; F Friedmacher; P Puri
Journal:  Pediatr Surg Int       Date:  2014-07-10       Impact factor: 1.827

Review 5.  Clinical management of inflammatory bowel disease in the organ recipient.

Authors:  Amedeo Indriolo; Paolo Ravelli
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 6.  Extracardiac Complications in Intensive Care Units after Surgical Repair for Congenital Heart Disease: Imaging Review with a Focus on Ultrasound and Radiography.

Authors:  Takahiro Hosokawa; Saki Shibuki; Yutaka Tanami; Yumiko Sato; Yoshihiro Ko; Koji Nomura; Eiji Oguma
Journal:  J Pediatr Intensive Care       Date:  2020-09-09

7.  Neutropenic Enterocolitis in a Pediatric Heart Transplant Recipient on Multiple Immunosuppressants.

Authors:  Emily E Miller; Leigh Christopher Reardon
Journal:  Case Rep Transplant       Date:  2018-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.